severe myopathy in patients taking both a statin and gemfibrozil (Lopid)

May 2001

How can you reduce the risk of severe myopathy in patients taking both a statin and gemfibrozil (Lopid)?

This combo is being used more these days...for patients who need to lower both LDL cholesterol and triglycerides.

The problem is that each drug can cause myopathy. The risk is low...but it's higher when the drugs are combined.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote